Oncternal Therapeutics Inc (FRA:GTU)
€ 5.32 0 (0%) Market Cap: 24.54 Mil Enterprise Value: -103,000.00 PE Ratio: 0 PB Ratio: 0.17 GF Score: 31/100

Q2 2019 Oncternal Therapeutics Inc Earnings Call Transcript

Aug 08, 2019 / 09:00PM GMT
Release Date Price: €76 (+9.83%)
Operator

Greetings, and welcome to Oncternal Therapeutics Q2 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Richard Vincent, Chief Financial Officer. Please go ahead.

Richard G. Vincent
Oncternal Therapeutics, Inc. - CFO

Thank you, operator. Good afternoon, everyone. I'd like to welcome you to our conference call to discuss Oncternal's second quarter financial results and provide an update of our clinical and preclinical development programs.

Earlier today, we issued our earnings release reporting financial results and business updates and plan to file our Form 10-Q for the quarter ended June 30, 2019 with the Securities and Exchange Commission tomorrow. Our filings and a replay of this call will be available on the Investors section of our website at www.oncternal.com for at least the next 30 days.

With me today is Oncternal's President and CEO, Dr. James

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot